PONATINIB EVALUATION AND SAFETY IN REAL LIFE CHRONIC PHASE (CP) CML PATIENTS FAILING >= 2 TYROSINE KINASE INHIBITORS (TKI): UPDATE OF THE PEARL OBSERVATIONAL STUDYF. E. Nicolini,M. Heiblig, D. Caillot,A. Charbonnier,P. Rousselot, V. Coiteux,M. Escoffre-Barbe,V. Dubruille, F. Huguet,F. Guilhot,E. Hermet, A. Guerci-Bresler,S. Ame, P. Mouchel,L. Roy,S. Morisset,G. Etienne,D. ReaHAEMATOLOGICA（2016）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
